Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Sat Kartar Shopping IPO
Price Band
₹77.0–81.0
Issue Size
₹33.8 Cr
Lot Size
1,600 shares
Min Investment
₹129,600
GMP
+₹40.0 (49.38%)
Issue Price
₹81.0
Subject to Sauda
₹48600
Paid only if allotted
Sat Kartar Shopping IPO AI Summary
- Sat Kartar Shopping IPO is listed on NSE SME in the Pharmaceuticals sector.
- Price band: ₹77.0–₹81.0 per share, lot size 1,600 shares (min. investment ₹129,600).
- Subscription window: 10 Jan–14 Jan 2025, listing on 17 Jan 2025.
- Current GMP is +₹40.0 (49.38%), an estimated listing price of ₹121 — unofficial and can change daily.
Sat Kartar Shopping Limited is an Ayurveda-focused healthcare company preparing for an IPO with a price band of ₹77.0 to ₹81.0. The company has shown significant growth in total income and profit over the past few years, with a strong digital presence and a focus on natural wellness solutions.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Sat Kartar Shopping IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 14 Jan 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Sat Kartar Shopping IPO Grey Market Premium (GMP) Today
GMP
+₹40.0
GMP %
+49.38%
Est. Listing
₹121.0
Updated: 25 Jul 2026 14:15
About the Company
Incorporated in June 2012, Sat Kartar Shopping Limited is an Ayurveda healthcare company focused on delivering natural wellness solutions for therapeutic and lifestyle products, promoting a healthier lifestyle. The company offers holistic, natural remedies and lifestyle products based on traditional Ayurveda practices, serving individual consumers directly. It sells products through its own website, third-party e-commerce platforms, television marketing, and Google and Meta applications. Their Products: Specific Problem Led Niche Therapeutic Areas: The company targets specialized fields within the medical and healthcare domain that focus on addressing specific health issues or challenges such as addiction, personal care, wellness, and others. Products are Addiction Killer,Liv Muztang etc. Lifestyle Led Curative Areas:The company also targets specialized fields within healthcare and medicine that focus on addressing health issues related to individuals' lifestyles, such as diabetes, joint pain relief, piles, and other health concerns. The company is diversifying its product portfolio to include products related to various health issues such as slimming, hair care, gut health, PCOD (Poly Cystic Ovary Disease), and mental wellness. As on November 30, 2024, the company has a total of 1,122 employees operating under various department. Competitive Strength: Emerging brand with PAN India presence Asset light Business Model Strong Digital Media presence. Anonymity of Customers In house research and development Clinical Trials Well Structured Logistics process
Company Financials (₹ Cr)
As of 2024-03-31
| Period Ended | 15 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 31.17 | 21.75 | 14.71 | 12.39 |
| Total Income | 109.55 | 128.11 | 82.98 | 52.31 |
| Profit After Tax | 5.90 | 6.31 | 2.51 | 1.39 |
| NET Worth | 17.28 | 9.43 | 3.27 | 0.77 |
| Reserves and Surplus | 5.71 | 6.63 | 2.57 | 0.07 |
| Total Borrowing | 4.03 | 1.78 | 3.75 | 8.15 |
Key Ratios
EPS
₹5.45
NAV
₹33.69
ROE
66.84%
ROCE
91.55%
RoNW
66.84%
P/B Value
2.40
P/E Ratio
14.87
Market Cap
₹127.53 Cr
PAT Margin
4.93%
Debt/Equity
0.19
Peer Comparison
| Company | P/E (x) | EPS Basic | EPS Diluted | RoNW |
|---|---|---|---|---|
| Kerala Ayurveda Ltd. | -182.66 | -1.47 | -1.47 | — |
| Jeena Sikho Lifecare Limited | 64.9 | 27.84 | 27.84 | — |
| Sat Kartar Shopping Limited This IPO | 14.87 | 22.52 | 22.52 | 66.84% |
Promoters
Manprit Singh Chadha, Pranav Singh Chadha, Simrati Kaur and Ajooni Wellness Pvt.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 To meet out the expenses of Unidentified Acquisition (In India or Abroad) 5.00 2 To meet out the expenses Marketing and Advertisement 11.00 3 To meet out the Capital Expenditure 8.00 4 To meet out the expenditure on Investment in Technology 5.00 5 To meet out the General corporate purposes 1.25 6 Issue Expenses 3.55 Total 33.80
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Total income was ₹52.31 Cr in the year ended 31 Mar 2022, rising to ₹82.98 Cr by 31 Mar 2023, then increasing further to ₹128.11 Cr by 31 Mar 2024. However, the most recent figure of ₹109.55 Cr as of 15 Dec 2024 is a 9-month figure and not a full year, so it isn't directly comparable.
Profit Trend
Profit after tax was ₹1.39 Cr in the year ended 31 Mar 2022, increasing to ₹2.51 Cr by 31 Mar 2023, and further rising to ₹6.31 Cr by 31 Mar 2024. The latest figure of ₹5.90 Cr as of 15 Dec 2024 is also a 9-month figure, making direct comparison with the full years less straightforward.
Valuation
Priced at roughly 14.87 trailing earnings, versus peers trading at a P/E range of -182.66 to 64.9.
Grey Market Premium, Explained
The grey market refers to the unofficial trading of shares before they are listed on the stock exchange. The Grey Market Premium (GMP) indicates the expected listing price of the shares based on demand in this market. A positive GMP suggests that the shares are likely to list at a higher price than the issue price.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their financial goals and risk tolerance. It's essential to consider the company's fundamentals and market conditions.
Who May Want to Wait
Investors who are risk-averse or not familiar with the healthcare sector may want to avoid this IPO, as it may involve higher volatility and uncertainty.
IPO Timeline, Explained
The IPO opens for subscription on 10 January 2025 and closes on 14 January 2025. Allotment of shares will be done on 15 January 2025, with the listing date set for 17 January 2025.
Listing Gains — The Risk
Listing gains are the profits made by investors when shares are sold on the listing day at a price higher than the issue price. However, these gains are not guaranteed and can be influenced by market conditions, investor sentiment, and the company's performance post-listing.
This evaluation is generated from Sat Kartar Shopping's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Sat Kartar Shopping IPO GMP today?
Sat Kartar Shopping IPO GMP today is +₹40.0 (49.38%), indicating an estimated listing price of ₹121. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Sat Kartar Shopping IPO?
The price band of Sat Kartar Shopping IPO is ₹77.0–₹81.0 per share.
When does Sat Kartar Shopping IPO open and close?
Sat Kartar Shopping IPO opens on 10 January 2025 and closes on 14 January 2025.
When does Sat Kartar Shopping IPO list on the stock exchange?
Sat Kartar Shopping IPO listed on 17 January 2025 at ₹121.0.
What is the lot size for Sat Kartar Shopping IPO?
The lot size for Sat Kartar Shopping IPO is 1600 shares, requiring a minimum investment of ₹129,600.
What is the price band for the IPO?
The price band for the IPO is ₹77.0 to ₹81.0.
What is the minimum investment required?
The minimum investment required is ₹129,600.
What is the lot size for the IPO?
The lot size for the IPO is 1,600 shares.
When does the IPO open and close?
The IPO opens on 10 January 2025 and closes on 14 January 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the shares based on demand in the grey market.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
10 Jan 2025
Close
14 Jan 2025
Allotment
15 Jan 2025
Listing
17 Jan 2025
Similar IPOs in Pharmaceuticals
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Sat Kartar Shopping?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.